Literature DB >> 20697548

Innate immunity in the adult mammalian heart: for whom the cell tolls.

Douglas L Mann1, Veli K Topkara, Sarah Evans, Philip M Barger.   

Abstract

Recent studies suggest that the heart possesses an intrinsic system that is intended to delimit tissue injury, as well as orchestrate homoeostatic responses within the heart. The extant literature suggests that this intrinsic stress response is mediated, at least in part, by a family of pattern recognition receptors that belong to the innate immune system, including CD14, the soluble pattern recognition receptor for lipopolysaccharide, and Toll like receptors-2, 3, 4, and 6. Although this intrinsic stress response system provides a short-term adaptive response to tissue injury, the beneficial effects of this phylogenetically ancient system may be lost if myocardial expression of these molecules either becomes sustained and/or excessive, in which case the salutary effects of activation of these pathways may be contravened by the known deleterious effects of inflammatory signaling. Herein we present new information with regard to activation of innate immune gene expression in the failing human heart. Taken together, these new observations provide provisional evidence that the innate immune system is activated in human heart failure, raising the interesting possibility that this pathway may represent a target for the development of novel heart failure therapeutics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20697548      PMCID: PMC2917144     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  32 in total

1.  Tumor necrosis factor and viral myocarditis: the fine line between innate and inappropriate immune responses in the heart.

Authors:  D L Mann
Journal:  Circulation       Date:  2001-02-06       Impact factor: 29.690

Review 2.  Danger signals: SOS to the immune system.

Authors:  S Gallucci; P Matzinger
Journal:  Curr Opin Immunol       Date:  2001-02       Impact factor: 7.486

3.  The extra domain A of fibronectin activates Toll-like receptor 4.

Authors:  Y Okamura; M Watari; E S Jerud; D W Young; S T Ishizaka; J Rose; J C Chow; J F Strauss
Journal:  J Biol Chem       Date:  2001-01-09       Impact factor: 5.157

4.  Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells.

Authors:  R M Vabulas; P Ahmad-Nejad; C da Costa; T Miethke; C J Kirschning; H Häcker; H Wagner
Journal:  J Biol Chem       Date:  2001-06-11       Impact factor: 5.157

5.  An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells.

Authors:  M Li; D F Carpio; Y Zheng; P Bruzzo; V Singh; F Ouaaz; R M Medzhitov; A A Beg
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

6.  CD14-independent activation of cardiomyocyte signal transduction by bacterial endotoxin.

Authors:  D B Cowan; D N Poutias; P J Del Nido; F X McGowan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-08       Impact factor: 4.733

7.  Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes.

Authors:  S Frantz; R A Kelly; T Bourcier
Journal:  J Biol Chem       Date:  2000-11-16       Impact factor: 5.157

8.  In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4.

Authors:  G Baumgarten; P Knuefermann; N Nozaki; N Sivasubramanian; D L Mann; J G Vallejo
Journal:  J Infect Dis       Date:  2001-04-23       Impact factor: 5.226

Review 9.  Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart.

Authors:  Wei Chao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-11-14       Impact factor: 4.733

10.  Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice.

Authors:  Yan Feng; Huailong Zhao; Xinhua Xu; Emmanuel S Buys; Michael J Raher; Jean C Bopassa; Helene Thibault; Marielle Scherrer-Crosbie; Ulrich Schmidt; Wei Chao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-25       Impact factor: 4.733

View more
  31 in total

Review 1.  Therapeutic targeting of innate immunity in the failing heart.

Authors:  Veli K Topkara; Sarah Evans; Weili Zhang; Slava Epelman; Lora Staloch; Philip M Barger; Douglas L Mann
Journal:  J Mol Cell Cardiol       Date:  2010-11-10       Impact factor: 5.000

Review 2.  Innate immunity and the failing heart: the cytokine hypothesis revisited.

Authors:  Douglas L Mann
Journal:  Circ Res       Date:  2015-03-27       Impact factor: 17.367

Review 3.  Skeletal muscle inflammation and atrophy in heart failure.

Authors:  Kory J Lavine; Oscar L Sierra
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

Review 4.  Reappraising the role of inflammation in heart failure.

Authors:  Luigi Adamo; Cibele Rocha-Resende; Sumanth D Prabhu; Douglas L Mann
Journal:  Nat Rev Cardiol       Date:  2020-01-22       Impact factor: 32.419

5.  Human induced pluripotent stem cell-derived mesenchymal stem cell therapy effectively reduced brain infarct volume and preserved neurological function in rat after acute intracranial hemorrhage.

Authors:  Kuan-Hung Chen; Kun-Chen Lin; Christopher Glenn Wallace; Yi-Chen Li; Pei-Lin Shao; John Y Chiang; Pei-Hsun Sung; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

6.  Mechanisms and management of doxorubicin cardiotoxicity.

Authors:  Y Shi; M Moon; S Dawood; B McManus; P P Liu
Journal:  Herz       Date:  2011-06       Impact factor: 1.443

7.  Molecular profiling of dilated cardiomyopathy that progresses to heart failure.

Authors:  Michael A Burke; Stephen Chang; Hiroko Wakimoto; Joshua M Gorham; David A Conner; Danos C Christodoulou; Michael G Parfenov; Steve R DePalma; Seda Eminaga; Tetsuo Konno; Jonathan G Seidman; Christine E Seidman
Journal:  JCI Insight       Date:  2016-05-05

8.  Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+/- Akita hearts.

Authors:  Vishalakshi Chavali; Suresh C Tyagi; Paras Kumar Mishra
Journal:  Cell Biochem Biophys       Date:  2014-01       Impact factor: 2.194

Review 9.  Viral myocarditis: from experimental models to molecular diagnosis in patients.

Authors:  Sabine Pankuweit; Karin Klingel
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

10.  Phylogenetic origin of LI-cadherin revealed by protein and gene structure analysis.

Authors:  R Jung; M W Wendeler; M Danevad; H Himmelbauer; R Gessner
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.